# Desmopressin as a Therapy for Bedwetting in Children With Sickle Cell Disease

> **NCT02636387** · — · TERMINATED · sponsor: **Montefiore Medical Center** · enrollment: 14 (actual)

## Conditions studied

- Nocturnal Enuresis
- Anemia, Sickle Cell

## Interventions

- **DRUG:** Desmopressin

## Key facts

- **NCT ID:** NCT02636387
- **Lead sponsor:** Montefiore Medical Center
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** TERMINATED
- **Start date:** 2015-08-26
- **Primary completion:** 2018-10-27
- **Final completion:** 2018-10-27
- **Target enrollment:** 14 (ACTUAL)
- **Why stopped:** Low recruitment
- **Last updated:** 2022-05-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02636387

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02636387, "Desmopressin as a Therapy for Bedwetting in Children With Sickle Cell Disease". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT02636387. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*